| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Health and Human Services, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
HIV infection leads to numerous immunologic defects, including impaired B cell function. An effective humoral response requires bidirectional interactions between B cells and CD4+ T cells, critical of which are interactions between CD80/CD86 expressed on activated B cells and CD28 expressed on responder CD4+ T cells. In the present study, we examined the effect of active HIV replication on B cell costimulatory function. Induction of CD80/CD86 on B cells following B cell receptor and CD40 triggering and responsiveness of CD4+ T cells to activated B cells were investigated in a system where B cells of HIV-infected patients were compared concurrently to B cells of HIV-negative donors. In contrast to HIV-aviremic patients, B cells of HIV-viremic patients were ineffective at stimulating CD4+ T cells, as measured by the induction of activation markers and proliferation. The importance of interactions of CD80/CD86 and CD28 in activating CD4+ T cells was clear; the ablation of a normal response following the addition of neutralizing anti-CD86/CD80 Abs mirrored the response of CD4+ T cells to B cells of HIV-viremic patients, while the addition of exogenous CD28 ligands partially restored the poor CD4+ T cell response to the B cells of HIV-viremic patients. Ineffective B cell costimulatory function in HIV-viremic patients was associated with low induction of CD80/CD86 expression on B cells. Our findings further delineate the scope of defects associated with cognate B cell-CD4+ T cell interactions in HIV infection and suggest that therapeutic interventions designed to enhance CD28-dependent costimulatory pathways may help restore immune functions.
This article has been cited by other articles:
|
|
 |
|
  J. C. Tilton, M. M. Manion, M. R. Luskin, A. J. Johnson, A. A. Patamawenu, C. W. Hallahan, N. A. Cogliano-Shutta, J. M. Mican, R. T. Davey Jr., S. Kottilil, et al. Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro J. Virol., April 15, 2008; 82(8): 3997 - 4006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Abzug, L.-Y. Song, T. Fenton, S. A. Nachman, M. J. Levin, H. M. Rosenblatt, S. I. Pelton, W. Borkowsky, K. M. Edwards, J. Peters, et al. Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy Pediatrics, November 1, 2007; 120(5): e1190 - e1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Alter, T. J. Suscovich, N. Teigen, A. Meier, H. Streeck, C. Brander, and M. Altfeld Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells J. Immunol., June 15, 2007; 178(12): 7658 - 7666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Martin, J. Roy, C. Barat, M. Ouellet, C. Gilbert, and M. J. Tremblay Human Immunodeficiency Virus Type 1-Associated CD40 Ligand Transactivates B Lymphocytes and Promotes Infection of CD4+ T Cells J. Virol., June 1, 2007; 81(11): 5872 - 5881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ho, S. Moir, A. Malaspina, M. L. Howell, W. Wang, A. C. DiPoto, M. A. O'Shea, G. A. Roby, R. Kwan, J. M. Mican, et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms PNAS, December 19, 2006; 103(51): 19436 - 19441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Tilton, A. J. Johnson, M. R. Luskin, M. M. Manion, J. Yang, J. W. Adelsberger, R. A. Lempicki, C. W. Hallahan, M. McLaughlin, J. M. Mican, et al. Diminished Production of Monocyte Proinflammatory Cytokines during Human Immunodeficiency Virus Viremia Is Mediated by Type I Interferons J. Virol., December 1, 2006; 80(23): 11486 - 11497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Malaspina, S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T.-W. Chun, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 PNAS, February 14, 2006; 103(7): 2262 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Feola and B. A. Garvy Combination Exposure to Zidovudine plus Sulfamethoxazole-Trimethoprim Diminishes B-Lymphocyte Immune Responses to Pneumocystis murina Infection in Healthy Mice Clin. Vaccine Immunol., February 1, 2006; 13(2): 193 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Andrade, J.-A. C. Portillo, M. Wessendarp, and C. S. Subauste CD40 Signaling in Macrophages Induces Activity against an Intracellular Pathogen Independently of Gamma Interferon and Reactive Nitrogen Intermediates Infect. Immun., May 1, 2005; 73(5): 3115 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Moir, A. Malaspina, O. K. Pickeral, E. T. Donoghue, J. Vasquez, N. J. Miller, S. R. Krishnan, M. A. Planta, J. F. Turney, J. S. Justement, et al. Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily J. Exp. Med., September 6, 2004; 200(5): 587 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. McLaren, M. Mayne, S. Rosser, T. Moffatt, K. G. Becker, F. A. Plummer, and K. R. Fowke Antigen-Specific Gene Expression Profiles of Peripheral Blood Mononuclear Cells Do Not Reflect Those of T-Lymphocyte Subsets Clin. Vaccine Immunol., September 1, 2004; 11(5): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Milito, A. Nilsson, K. Titanji, R. Thorstensson, E. Reizenstein, M. Narita, S. Grutzmeier, A. Sonnerborg, and F. Chiodi Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection Blood, March 15, 2004; 103(6): 2180 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stebbing, B. Gazzard, S. Patterson, M. Bower, D. Perumal, M. Nelson, A. McMichael, G. Ogg, A. Epenetos, F. Gotch, et al. Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination Blood, March 1, 2004; 103(5): 1791 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mavilio, J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M. A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, et al. Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates PNAS, December 9, 2003; 100(25): 15011 - 15016. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
